Expression of mRNA for growth factors and extracellular matrix proteins after injury to cultured peritoneal cells: Does the healing process contribute to peritoneal ultrastructural alteration?

Journal of Artificial Organs

Volumn 6, Issue 4, 2003, Pages 253-259

  Fujikawa, Koki ^a,d   Takai, Kimio ^a   Suga, Akinobu ^a   Naito, Katusuke ^a   Ohata, Atushi ^b   Nakasone, Shinya ^c   Horiuchi, Takashi ^c  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF EAST ASIA   (Japan)

^d Tokuyama Central Hospital   (Japan)

Author keywords

CAPD; Growth factors; Matrix proteins; RPFB; RPMC; Wound healing

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GROWTH FACTOR; MESSENGER RNA; SCATTER FACTOR; SCLEROPROTEIN; SODIUM HYDROXIDE; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL MEMBRANE; DIALYSATE; EXTRACELLULAR MATRIX; FIBROBLAST; FIBROSIS; HEALING; HYPERPLASIA; INJURY; MESOTHELIUM CELL; MONOLAYER CULTURE; NONHUMAN; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRASTRUCTURE; UPREGULATION;

ANIMALS; BASE SEQUENCE; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; EXTRACELLULAR MATRIX PROTEINS; FEMALE; FIBROBLASTS; GROWTH SUBSTANCES; MALE; MOLECULAR SEQUENCE DATA; PERITONEUM; PERITONITIS; PROBABILITY; RATS; RATS, WISTAR; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; WOUND HEALING;

EID: 0344290727     PISSN: 14347229     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10047-003-0236-6     Document Type: Article

References (27)

1. Coles GA, Topley N. Long-term peritoneal membrane changes. Adv Ren Replace Ther 2000;7:289-301
2. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S, Geis WP, Hano JE. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980;140:1201-1203
3. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992;12:14-27
4. Suassuna JHR, Das Neves FC, Hartley RB, Ogg CS, Cameron JS. Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 1994;46:443-454
5. Topley N. Membrane longevity in peritoneal dialysis: Impact of infection and bio-incompatible solution. Adv Ren Replace Ther 1998;5:179-184
6. Horiuchi T, Hayashi K, Beavis MJ, Williams JD, Topley N. Expression of transforming growth factor (TGF)-β1 mRNA and contractility of extra-cellular matrices in three-dimensional culture of rat peritoneal fibroblasts. Clin Exp Nephrol 2000;4:105-113
7. Horiuchi T, Inoue T, Nagasawa K. Prolonged preservation of rat peritoneal mesothelial cells (RPMC) and rat peritoneal fibroblasts (RPFB) with neutral pH peritoneal dialysis solution depleted of glucose degradation products (GDPs). Clin Exp Nephrol 2001;5:257-264
8. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990;37:1563-1570
9. Webb KE, Henney AM, Anglin S, Humphries SE, McEwan JR. Expression of matrix metalloproteinases and their inhibitor TIMP-1 on the rat carotid artery after balloon injury. Arterioscler Thromb Vasc Biol 1997;17:1837-1844
10. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor beta. Nucleic Acids Res 1990;18:3059-3065
11. Ishibashi T, Shinogami M, Ishimoto S, Yoshida K, Kaga K. Induction of KGF, basic FGF, and TGFα mRNA expression during healing of experimental TM perforations. Acta Otolaryngol 1998;118:701-704
12. Lai GH, Radaeva S, Nakamura T, Sirica AE. Unique epithelial cell production of hepatocyte growth factor/scatter factor by putative precancerous intestinal metaplasia and associated intestinal-type biliary cancer chemically induced in rat liver. Hepatology 2000;31:1257-1265
13. Inagi R, Miyata T, Kurokawa K. Glucose degradation product methylglyoxal enhances the production of vascular endothelial growth factor in peritoneal cells: role in the functional and morphological alterations of peritoneal membranes in peritoneal dialysis. FEBS Lett 1999;463:260-264
14. Cai X, Foster SC, Liu JJ, Kupferman AE, Filipec M, Colvin RB, Lee SJ. Alternatively spliced fibronectin molecules in the wounded cornea: Analysis by PCR. Invest Ophthalmol Vis Sci 1993;34:3585-3592
15. Ryan GB, Grobety J, Majno G. Mesothelial injury and recovery. Am J Pathol 1973;71:93-112
16. Yamamoto T, Sakakura T, Yamakawa M, Horiuchi N, Hirata S, Iritani Y, Nishitani H, Kim M, Kishimoto T, Chiku T. Clinical effects of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992;60:324-329
17. Offner FA, Feichtinger H, Stadlmann S, Obrist P, Marth C, Klinglet P, Grage B, Schmahl M, Knabbe C. Tansforming growth factor-β synthesis by human peritoneal mesothelial cells: Induction by interleukin-1. Am J Pathol 1996;148:1679-1688
18. Border WA, Rouslahti E. Transforming growth factor-β in disease: The dark side of tissue repair. J Clin Invest 1992;90:1-7
19. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991;3:67-85
20. Cantley LG, Barros EJ, Gandhi M. Regulation of mitogenesis, motogenesis, and tubulogenesis by hepatocyte growth factor in renal collecting duct cells. Am J Physiol 1994;267:271-280
21. Wang T, Ghen YG, Ye RG, Li SL, Li HQ, Chen YX. Effect of glucose on TGFβ-1 expression in peritoneal mesothelial cells. Adv Perit Dial 1995;11:7-10
22. Montesano R, Vassalli JD, Orci L. Basic fibroblast growth factor induces angiogenesis in vitro. Proc Natl Acad Sci USA 1986;83:7297-7301
23. Keck PJ, Hauser SD, Krivi G, Ferrara N. Vascular permeability factor, an endothelial mitogen related to PDGF. Science 1989;246:1309-1312
24. Zweers MM, Waart DR, Struijk DG, Krediet RT. The growth factors VEGF and TGFβ-1 in peritoneal dialysis. Kidney Int 1999;55(6):2602
25. Jorres A, Ludat K, Sander K, Dunkel K, Gahl GM. The peritoneal fibroblast and the control of peritoneal inflammation. Kidney Int 1996;50 (suppl 56):22-27
26. Selman M, King TE, Pardo A. Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann Intern Med 2001;134:136-151
27. Redington AE, Madden J, Frew AJ, Djukanovic R, Roche WR, Holgate ST, Howarth PH. Transforming growth factor-β-1 in asthma: Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1997;156:642-647